RxStrategies
RxStrategies, now merged into Pillr Health, provides 340B drug pricing program technology and services — including the Pillr One and Highbridge platforms, a 340B Dashboard, and the eCAP pharmacy accelerator — for pharmacies and covered entities such as Community Health Centers.
- Company typePrivate
- Founded2003
- HeadquartersBoca Raton, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What RxStrategies does
RxStrategies, founded in 2003 and headquartered in Boca Raton, Florida, is a private U.S. company that has built a proprietary technology and services platform around the federal 340B drug pricing program. The company's product portfolio centers on 340B program management for pharmacies and covered entities (including Community Health Centers), with core technology components including the Pillr One and Highbridge 340B technology platforms, a web-based 340B Dashboard for program management and oversight, and the eCAP pharmacy accelerator solution. Adjacent service offerings span program management, referral capture, audits and compliance, consulting and advisory, pharmacy optimization, and turnkey pharmacy setup — yielding a platform-plus-services architecture rather than a standalone software product.
The company's business model combines technology licensing/usage with services revenue. Distribution is primarily through a self-serve web portal (app.340bdashboard.com) targeted at mid-market pharmacy buyers, supplemented by direct customer engagement and content marketing via LinkedIn, an email newsletter, blog/clinical insights, and industry events. Pricing is not publicly disclosed. In 2025, RxStrategies announced a merger with Hudson Headwaters 340B and RPh Innovations to form Pillr Health, a unified organization that consolidates three specialized 340B providers under a single brand; the original RxStrategies entity is no longer operating independently. Headcount was reported in the 11–50 range prior to the merger, and no revenue figures have been disclosed.
RxStrategies firmographics
Firmographics- Name
- RxStrategies
- Website
- https://rxstrategies.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- RxStrategies, now merged into Pillr Health, provides 340B drug pricing program technology and services — including the Pillr One and Highbridge platforms, a 340B Dashboard, and the eCAP pharmacy accelerator — for pharmacies and covered entities such as Community Health Centers.
- Ownership category
- akta.pro rank
RxStrategies industry classification
Industry- Product category
- 340B Pharmacy Solutions
- NAICS
- Custom Computer Programming Services (541511), Computer Systems Design Services (541512)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Services-Prepackaged Software (7372), Services-Management Consulting Services (8742)
- akta.pro primary industry
- 340B Program Administration & Contract Pharmacy Services (HLAFALAL)
- akta.pro secondary industries
- Medication Therapy Management (MTM) & Clinical Pharmacy Services (HLAFALAH), PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools) (HLAEAKAL)
Keywords
Where RxStrategies is headquartered
LocationHeadquarters
- HQ city
- Boca Raton
- HQ country
- United States
- HQ region
- North America
Markets served
RxStrategies business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Distribution channels1 record
Marketing channels4 records
RxStrategies product offering
Product offeringCore offering
RxStrategies provides a proprietary turnkey solution enabling Community Health Centers and pharmacies participating in the federal 340B drug pricing program to manage program compliance, capture referrals, and optimize pharmacy financial performance. The portfolio includes two 340B technology platforms (Pillr One and Highbridge), four service lines (Program Management, Referral Capture, Audits and Compliance, Consulting and Advisory), and a Pharmacy Accelerator program (eCAP) offering pharmacy optimization and turnkey pharmacy setup.
Product overview
RxStrategies has merged with Hudson Headwaters 340B and RPh Innovations to form Pillr Health, a unified organization offering a comprehensive 340B pharmacy solutions platform. The portfolio consists of two technology platforms (Pillr One and Highbridge) for 340B program management, four service offerings (Program Management, Referral Capture, Audits and Compliance, Consulting and Advisory), and the Pharmacy Accelerator program (eCAP) with associated services including Pharmacy Optimization and Turnkey Pharmacy. This platform-plus-services architecture enables pharmacies to access both technological tools and expert support for their 340B programs.
Differentiator
Problem solved
Functional benefit
Brands
- Pillr One: 340B Technology platform solution
- Highbridge
- eCAP
Products and services
- Pillr One 340B technology platform providing comprehensive pharmacy management and optimization solutions for pharmacies participating in the 340B drug pricing program.
- Highbridge 340B technology solution for pharmacy operations and 340B program management.
- Program Management Comprehensive 340B program management services for pharmacies to operate and oversee their 340B drug pricing program.
- Referral Capture Service focused on capturing and managing pharmacy referrals within the 340B program.
- Audits and Compliance Audit and compliance services ensuring adherence to 340B program requirements.
- Consulting and Advisory Expert consulting services for 340B program strategy and optimization.
- eCAP (Pharmacy Accelerator) Pharmacy accelerator program providing technology and support for pharmacy operations and optimization.
- Pharmacy Optimization Service focused on optimizing pharmacy operations and financial performance.
- Turnkey Pharmacy Comprehensive turnkey solution for establishing and running pharmacy operations, including technology, compliance, and operational support.
Companies that use RxStrategies
Customer profileSegments1 record
Ideal customer profiles2 records
RxStrategies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
RxStrategies partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights5 records
RxStrategies competitors and assessment
Company assessmentDirect peers
- Macro Helix: Macro Helix provides 340B program management software and services to covered entities and contract pharmacies, directly competing with RxStrategies' Pillr One and Program Management offerings.
- CaptureRx: CaptureRx is a 340B solutions company specializing in contract pharmacy program administration and software, closely overlapping RxStrategies' core 340B tech and services.
- Sentry Data Systems: Sentry Data Systems offers 340B software, analytics, and program management solutions for hospitals, FQHCs, and contract pharmacies, making it a head-to-head competitor.
- Verity Solutions: Verity Solutions provides 340B audit and compliance software plus program management services, directly comparable to RxStrategies' Audits and Compliance and program offerings.
- SunRx: SunRx delivers 340B program management and contract pharmacy services, operating in the same niche as RxStrategies with similar covered-entity customers.
- Pharmaceutical Strategies Group (PSG): PSG provides 340B consulting, advisory, and program management services, overlapping with RxStrategies' Consulting and Advisory and Audit lines.
- Visante: Visante is a specialty pharmacy and 340B consulting firm, comparable to RxStrategies' advisory and pharmacy optimization offerings.
Emerging players
- Atlantic Management: Atlantic Management provides 340B contract pharmacy administration and related pharmacy services, a smaller niche player competing in the same space.
Broad incumbents
- Apexus (340B Prime Vendor Program): Apexus administers the federal 340B Prime Vendor Program, setting the broader ecosystem in which RxStrategies operates as a software and services vendor.
- McKesson RxO / Macro Helix-style PBM 340B tooling: Large drug distributors and PBMs (e.g., McKesson, AmerisourceBergen, Walgreens) bundle 340B admin and contract pharmacy services at scale, representing large incumbents competing for the same covered entities.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
RxStrategies social profiles
Digital presenceRxStrategies financial estimates
Financial estimateRevenue estimate
Valuation estimate
RxStrategies leadership team
Management profileNumber of profiles
Profiles2 records
RxStrategies funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RxStrategies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RxStrategies
What does RxStrategies do?
RxStrategies provides a proprietary turnkey solution enabling Community Health Centers and pharmacies participating in the federal 340B drug pricing program to manage program compliance, capture referrals, and optimize pharmacy financial performance. The portfolio includes two 340B technology platforms (Pillr One and Highbridge), four service lines (Program Management, Referral Capture, Audits and Compliance, Consulting and Advisory), and a Pharmacy Accelerator program (eCAP) offering pharmacy optimization and turnkey pharmacy setup.
When was RxStrategies founded?
RxStrategies was founded in 2003. It employs 11 to 50 people.
Where is RxStrategies based?
RxStrategies is headquartered in Boca Raton, United States, in the North America region.
Who are RxStrategies's main competitors?
Direct peers on record are Macro Helix, CaptureRx, Sentry Data Systems, Verity Solutions, SunRx, Pharmaceutical Strategies Group (PSG) and Visante. Atlantic Management is listed as an emerging player. Broad incumbents are Apexus (340B Prime Vendor Program) and McKesson RxO / Macro Helix-style PBM 340B tooling.
Does RxStrategies have an API?
No public API is recorded for RxStrategies.
What industry is RxStrategies in?
RxStrategies's product category is 340B Pharmacy Solutions. Its primary akta.pro industry code is HLAFALAL, 340B Program Administration & Contract Pharmacy Services, with a secondary code of HLAFALAH, Medication Therapy Management (MTM) & Clinical Pharmacy Services. Its NAICS code is 541511 and its SIC code is 5122.